Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits
Journal of the American Pharmacists Association · 2023
DOI: 10.1016/j.japh.2023.04.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2023. Verfasst von Eric Herber und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Telemedicine, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Herber, E., Bondar, A., Hockings, J., Hermiller, T., Russo-Alvarez, G., Wang, L., & Schulz, L. (2023). Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2023.04.021
Vancouver
Herber E, Bondar A, Hockings J, Hermiller T, Russo-Alvarez G, Wang L, et al. Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits. Journal of the American Pharmacists Association. 2023. doi:10.1016/j.japh.2023.04.021
BibTeX
@article{Herber2023,
author = {Herber, Eric and Bondar, Anna and Hockings, Jennifer and Hermiller, Taylor and Russo-Alvarez, Giavanna and Wang, Lu and Schulz, Lauren},
title = {Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits},
journal = {Journal of the American Pharmacists Association},
year = {2023},
doi = {10.1016/j.japh.2023.04.021}
}
EUVIMED